Time flies with great content! Renew in to keep enjoying all our premium content.
Prime
Kenyan firm wins entry into global drugs market
A chemist displays drugs in Nyeri. Universal Corporation’s Lamozid, an anti-retroviral drug, was pre-qualified last Friday and included in a list of about 255 drugs approved for the fund which spends Sh2 trillion annually on combating malaria, Aids, tuberculosis, and more recently, reproductive health. File
A Kenyan pharmaceutical company has won World Health Organisation (WHO) certification for one of its drugs, opening the door to lucrative tenders floated by the Global Fund.
Universal Corporation’s Lamozid, an anti-retroviral drug, was pre-qualified last Friday and included in a list of about 255 drugs approved for the fund which spends Sh2 trillion annually on combating malaria, Aids, tuberculosis, and more recently, reproductive health.
